Info

Deltanoid Pharmaceuticals Inc. is a dynamic, privately funded biopharmaceutical company based in Madison, Wisconsin, engaged in research, development and commercialization of novel therapies for the treatment of human diseases. The company was founded to advance the development of raw university inventions, with an initial focus on vitamin D and other compounds licensed from the Wisconsin Alumni Research Foundation. Deltanoid's continued focus is to develop selected therapies through early phases of the drug development process and seek partners for later stage development and commercialization in a wide variety of therapeutic areas, including osteoporosis, renal diseases, psoriasis, autoimmune diseases and cancer. Currently, Deltanoid has two active partnership agreements in place with QuatRx Pharmaceuticals (topical treatment for psoriasis) and Primus Pharmaceutical (non-FDA approved medical foods for bone health).